These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22333393)

  • 21. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
    Wang B; Wang H; Zhao A; Zhang M; Yang J
    BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NAT1 is a critical prognostic biomarker and inhibits proliferation of colorectal cancer through modulation of PI3K/Akt/mTOR.
    Cai J; Sun H; Chen L; Xie M; Zhuang J; Gao L; Wei XX
    Future Oncol; 2021 Jul; 17(19):2489-2498. PubMed ID: 33906370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
    Carlisle SM; Trainor PJ; Doll MA; Stepp MW; Klinge CM; Hein DW
    Mol Carcinog; 2018 Nov; 57(11):1458-1466. PubMed ID: 29964355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer.
    Coulson-Gilmer C; Humphries MP; Sundara Rajan S; Droop A; Jackson S; Condon A; Cserni G; Jordan LB; Jones LJ; Kanthan R; Di Benedetto A; Mottolese M; Provenzano E; Kulka J; Shaaban AM; Hanby AM; Speirs V
    J Pathol Clin Res; 2018 Oct; 4(4):241-249. PubMed ID: 29956502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.
    Masci G; Caruso M; Caruso F; Salvini P; Carnaghi C; Giordano L; Miserocchi V; Losurdo A; Zuradelli M; Torrisi R; Di Tommaso L; Tinterri C; Testori A; Garcia-Etienne CA; Gatzemeier W; Santoro A
    Oncologist; 2015 Jun; 20(6):586-92. PubMed ID: 25948676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Male breast cancer in the veterans affairs population: a comparative analysis.
    Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
    Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High N-Acetyltransferase 1 Expression Is Associated with Estrogen Receptor Expression in Breast Tumors, but Is not Under Direct Regulation by Estradiol, 5
    Zhang X; Carlisle SM; Doll MA; Martin RCG; States JC; Klinge CM; Hein DW
    J Pharmacol Exp Ther; 2018 Apr; 365(1):84-93. PubMed ID: 29339455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of two androgen-induced markers (apolipoprotein D and pepsinogen C) in female and male breast carcinoma.
    Serra C; Vizoso F; Lamelas ML; Rodríguez JC; González LO; Merino AM; Baltasar A; Pérez-Vázquez MT; Medrano J
    Int J Surg Investig; 2000; 2(3):183-92. PubMed ID: 12678518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
    Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
    Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
    Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
    Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissues.
    Kim SJ; Kang HS; Jung SY; Min SY; Lee S; Kim SW; Kwon Y; Lee KS; Shin KH; Ro J
    J Mol Med (Berl); 2010 Nov; 88(11):1123-31. PubMed ID: 20628863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of NAT1 pharmacogene in hormone receptor positive vs. negative female breast tumors may affect drug treatment.
    Ivanova D; Fakis G; Boukouvala S
    Pharmacogenet Genomics; 2024 Sep; 34(7):246-251. PubMed ID: 38842463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.
    Asleh-Aburaya K; Sheffield BS; Kos Z; Won JR; Wang XQ; Gao D; Wolber R; Gilks CB; Bernard PS; Chia SK; Nielsen TO
    Histopathology; 2017 Jan; 70(2):185-194. PubMed ID: 27402148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic characteristics and survival of male breast cancer.
    Liu D; Xie G; Chen M
    Int J Clin Oncol; 2014 Apr; 19(2):280-7. PubMed ID: 23640121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer.
    Aleskandarany MA; Green AR; Benhasouna AA; Barros FF; Neal K; Reis-Filho JS; Ellis IO; Rakha EA
    Breast Cancer Res; 2012 Jan; 14(1):R3. PubMed ID: 22225836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis on the clinical and prognostic features of 71 male patients with breast cancer].
    Liu DY; Xie GR; Chen M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Feb; 34(2):187-90. PubMed ID: 23751479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool.
    dos-Santos PB; Zanetti JS; Vieira-de-Mello GS; Rêgo MB; Ribeiro-Silva A A; Beltrão EI
    Int J Clin Exp Pathol; 2014; 7(5):2337-49. PubMed ID: 24966944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
    Amirifard N; Sadeghi E
    Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer.
    Ochnik AM; Baxter RC
    BMC Cancer; 2017 Dec; 17(1):820. PubMed ID: 29207959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.